Dendritic cell therapy for oncology roundtable conference

Por Tuyaerts, Sandra
Publicado em 2011

Potential Therapeutic Targets in Uterine Sarcomas

Por Cuppens, Tine, Tuyaerts, Sandra, Amant, Frédéric
Publicado no Sarcoma (2015)

Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy

Por Vanderstraeten, Anke, Luyten, Catherine, Verbist, Godelieve, Tuyaerts, Sandra, Amant, Frederic
Publicado em 2014

Dendritic cell immunotherapy in uterine cancer

Por Coosemans, An, Tuyaerts, Sandra, Vanderstraeten, Anke, Vergote, Ignace, Amant, Frédéric, Van Gool, Stefaan W
Publicado em 2014

In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer

Por Vanderstraeten, Anke, Tuyaerts, Sandra, Everaert, Tina, Van Bree, Rieta, Verbist, Godelieve, Luyten, Cathérine, Amant, Frederic
Publicado no Int J Mol Sci (2016)

Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations

Por Madondo, Mutsa T, Tuyaerts, Sandra, Turnbull, Brit B, Vanderstraeten, Anke, Kohrt, Holbrook, Narasimhan, Balasubramanian, Amant, Frederic, Quinn, Michael, Plebanski, Magdalena
Publicado em 2014

Approaches to Advance Cancer Vaccines to Clinical Utility

Publicado em 2019